Strontium ranelate promotes increased peri-implant bone formation in ovariectomized rats.
DOI:
https://doi.org/10.33448/rsd-v9i10.9092Keywords:
Osteoporosis; Strontium; Osseointegration; Bone.Abstract
This study aimed to evaluate the systemic effect of strontium ranelate (SR) on peri-implant bone tissue. Thirty-six adult rats were divided into three experimental groups: sham (SHAM), ovariectomized (OVX) and ovariectomized rats treated with strontium ranelate (OVX-Sr). Strontium ranelate (625mg/kg) was administered by oral gavage on a daily basis. The implants were installed on the tibiae. The euthanasia occurred 42 and 60 days after the implants were installed, and the biomechanical (reverse torque); PCR-RT; histological; immunohistochemical; confocal microscopy and histometric analysis were performed. Quantitative data was subjected to statistical tests with significance level set at p<0.05. Significant increase in implant reverse torque in OVX-Sr was observed when compared to OVX. PCR analysis showed an increase in the genetic expression of the proteins responsible for bone formation in OVX-SR. In the histological analysis, SHAM and OVX-Sr showed a higher degree of maturation of peri-implant bone tissue. Ran-Sr presented higher immunolabeling for ALP and OPN proteins when compared to OVX. In the confocal microscopy, OVX-Sr there was good bone neoformation showed by incorporation of Alizarin red fluorochrome. The histometric analysis, bone implant contact (BIC) and neoformed bone area (NBA) presented statistically difference among all groups, and the Ran-Sr presented the highest BIC. Thus, strontium ranelate improves osseointegration and quality of neoformed bone tissue around implants in estrogen deficient rats.
References
Abrahamsen, B., Grove, E. L., & Vestergaard, P. (2014). Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporosis international, 25(2), 757–762. https://doi.org/10.1007/s00198-013-2469-4
Bain, S. D., Jerome, C., Shen, V., Dupin-Roger, I., & Ammann, P. (2009). Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporosis international, 20(8), 1417–1428. https://doi.org/10.1007/s00198-008-0815-8.
Beattie, J. R., Sophocleous, A., Caraher, M. C., O'Driscoll, O., Cummins, N. M., Bell, S., Towler, M., Rahimnejad Yazdi, A., Ralston, S. H., & Idris, A. I. (2019). Raman spectroscopy as a predictive tool for monitoring osteoporosis therapy in a rat model of postmenopausal osteoporosis. Journal of materials science. Materials in medicine, 30(2), 25. https://doi.org/10.1007/s10856-019-6226-x
Blake, G. M., & Fogelman, I. (2006). Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment. Journal of bone and mineral research, 21(9), 1417–1424. https://doi.org/10.1359/jbmr.060616
Brennan, T. C., Rybchyn, M. S., Green, W., Atwa, S., Conigrave, A. D., & Mason, R. S. (2009). Osteoblasts play key roles in the mechanisms of action of strontium ranelate. British journal of pharmacology, 157(7), 1291–1300. https://doi.org/10.1111/j.1476-5381.2009.00305.x
Bonnelye, E., Chabadel, A., Saltel, F., & Jurdic, P. (2008). Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone, 42(1), 129–138. https://doi.org/10.1016/j.bone.2007.08.043
Bouxsein, M.L., Boyd, S.K., Christiansen, B.A., Guldberg, R.E., Jepsen, K.J. & Müller, R. (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 25(7):1468-86. https://doi.org/10.1002/jbmr.141.
Cianferotti, L., D'Asta, F., & Brandi, M. L. (2013). A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Therapeutic advances in musculoskeletal disease, 5(3), 127–139. https://doi.org/10.1177/1759720X13483187
Cooper, C., Fox, K. M., & Borer, J. S. (2014). Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD. Osteoporosis international, 25(2), 737–745. https://doi.org/10.1007/s00198-013-2582-4
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019). Osteoporosis. Lancet (London, England), 393(10169), 364–376. https://doi.org/10.1016/S0140-6736(18)32112-3
Confavreux, C. B., Canoui-Poitrine, F., Schott, A. M., Ambrosi, V., Tainturier, V., & Chapurlat, R. D. (2012). Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database. European journal of endocrinology, 166(4), 735–741. https://doi.org/10.1530/EJE-11-0959
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., Lindsay, R., & National Osteoporosis Foundation (2014). Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporosis international, 25(10), 2359–2381. https://doi.org/10.1007/s00198-014-2794-2
Dempster, D.W., Compston, J.E., Drezner, M.K., Glorieux, F.H., Kanis, J.A. & Malluche, H. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 28(1):2-17.
European Medicines Agency PSUR assessment report: Strontium ranelate. 2013. [Accessed June, 08, 2014]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR__Assessment_Report_-_Variation/human/000560/WC500147168.pdf
Faverani, L. P., Polo, T., Ramalho-Ferreira, G., Momesso, G., Hassumi, J. S., Rossi, A. C., Freire, A. R., Prado, F. B., Luvizuto, E. R., Gruber, R., & Okamoto, R. (2018). Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats. Clinical oral investigations, 22(1), 255–265. https://doi.org/10.1007/s00784-017-2106-2
Glösel, B., Kuchler, U., Watzek, G., & Gruber, R. (2010). Review of dental implant rat research models simulating osteoporosis or diabetes. The International journal of oral & maxillofacial implants, 25(3), 516–524.
Grynpas, M. D., & Marie, P. J. (1990). Effects of low doses of strontium on bone quality and quantity in rats. Bone, 11(5), 313–319. https://doi.org/10.1016/8756-3282(90)90086-e
Hamdy N. A. (2009). Strontium ranelate improves bone microarchitecture in osteoporosis. Rheumatology (Oxford, England), 48 Suppl 4, iv9–iv13. https://doi.org/10.1093/rheumatology/kep274
Hurtel-Lemaire, A. S., Mentaverri, R., Caudrillier, A., Cournarie, F., Wattel, A., Kamel, S., Terwilliger, E. F., Brown, E. M., & Brazier, M. (2009). The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. The Journal of biological chemistry, 284(1), 575–584. https://doi.org/10.1074/jbc.M801668200.
International Osteoporosis Foundation [Accessed June, 08, 2014]. Available from: https://www.iofbonehealth.org/
Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M. & Altman, D.G. (2010) Improving bioscience reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 29;8(6):e1000412. https://doi.org/10.1371/journal.pbio.1000412.
Maïmoun, L., Brennan, T. C., Badoud, I., Dubois-Ferriere, V., Rizzoli, R., & Ammann, P. (2010). Strontium ranelate improves implant osseointegration. Bone, 46(5), 1436–1441. https://doi.org/10.1016/j.bone.2010.01.379
Manrique, N., Pereira, C.C., Luvizuto, E.R., Sánchez, M. del P., Okamoto, T., Okamoto, R., Sumida, D.H. & Antoniali, C. (2015) Hypertension modifies OPG, RANK, and RANKL expression. during the dental socket bone healing process in spontaneously hypertensive rats. Clin Oral Investig. 19(6):1319-27. https://doi.org/10.1007/s00784-014-1369-0.
Marie, P. J., Ammann, P., Boivin, G., & Rey, C. (2001). Mechanisms of action and therapeutic potential of strontium in bone. Calcified tissue international, 69(3), 121–129. https://doi.org/10.1007/s002230010055
Marie P. J. (2005). Strontium as therapy for osteoporosis. Current opinion in pharmacology, 5(6), 633–636. https://doi.org/10.1016/j.coph.2005.05.005
Martín-Merino, E., Petersen, I., Hawley, S., Álvarez-Gutierrez, A., Khalid, S., Llorente-Garcia, A., Delmestri, A., Javaid, M. K., Van Staa, T. P., Judge, A., Cooper, C., & Prieto-Alhambra, D. (2018). Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporosis international, 29(2), 467–478. https://doi.org/10.1007/s00198-017-4308-5
Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E. M., Pors-Nielsen, S., Rizzoli, R., Genant, H. K., & Reginster, J. Y. (2004). The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. The New England journal of medicine, 350(5), 459–468. https://doi.org/10.1056/NEJMoa022436.
Palin, L.P., Polo, T.O.B., Batista, F.R.S., Gomes-Ferreira, P.H.S., Garcia-Junior, I.R., Rossi, A.C., Freire, A., Faverani, L.P., Sumida, D.H. & Okamoto, R. (2018) Daily melatonin administration improves osseointegration in pinealectomized rats. J Appl Oral Sci. 10;26: e20170470. https://doi.org/10.1590/1678-7757-2017-0470.
Pedrosa, W.F. Jr, Okamoto, R., Faria, P.E., Arnez, M.F., Xavier, S.P. & Salata, L.A. (2009) Immunohistochemical, tomographic and histological study on onlay bone graft remodeling. Part II: calvarial bone. Clin Oral Implants Res. 20(11):1254-64. https://doi.org/10.1111/j.1600-0501.2009.01747.x.
Pilmane, M., Salma-Ancane, K., Loca, D., Locs, J., & Berzina-Cimdina, L. (2017). Strontium and strontium ranelate: Historical review of some of their functions. Materials science & engineering. C, Materials for biological applications, 78, 1222–1230. https://doi.org/10.1016/j.msec.2017.05.042
Ramalho-Ferreira, G., Faverani, L. P., Prado, F. B., Garcia, I. R., Jr, & Okamoto, R. (2015). Raloxifene enhances peri-implant bone healing in osteoporotic rats. International journal of oral and maxillofacial surgery, 44(6), 798–805. https://doi.org/10.1016/j.ijom.2015.02.018
Ramalho-Ferreira, G., Faverani, L. P., Momesso, G., Luvizuto, E. R., de Oliveira Puttini, I., & Okamoto, R. (2017). Effect of antiresorptive drugs in the alveolar bone healing. A histometric and immunohistochemical study in ovariectomized rats. Clinical oral investigations, 21(5), 1485–1494. https://doi.org/10.1007/s00784-016-1909-x
Reginster, J. Y., Sarlet, N., Lejeune, E., & Leonori, L. (2005). Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action. Current osteoporosis reports, 3(1), 30–34. https://doi.org/10.1007/s11914-005-0025-7
Reginster, J. Y., Brandi, M. L., Cannata-Andía, J., Cooper, C., Cortet, B., Feron, J. M., Genant, H., Palacios, S., Ringe, J. D., & Rizzoli, R. (2015). The position of strontium ranelate in today's management of osteoporosis. Osteoporosis international, 26(6), 1667–1671. https://doi.org/10.1007/s00198-015-3109-y
Scardueli, C. R., Bizelli-Silveira, C., Marcantonio, R., Marcantonio, E., Jr, Stavropoulos, A., & Spin-Neto, R. (2018). Systemic administration of strontium ranelate to enhance the osseointegration of implants: systematic review of animal studies. International journal of implant dentistry, 4(1), 21. https://doi.org/10.1186/s40729-018-0132-8
Stevenson, M., Davis, S., Lloyd-Jones, M., & Beverley, C. (2007). The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women. Health technology assessment (Winchester, England), 11(4), 1–134. https://doi.org/10.3310/hta11040
Tarantino, U., Iolascon, G., Cianferotti, L., Masi, L., Marcucci, G., Giusti, F., Marini, F., Parri, S., Feola, M., Rao, C., Piccirilli, E., Zanetti, E. B., Cittadini, N., Alvaro, R., Moretti, A., Calafiore, D., Toro, G., Gimigliano, F., Resmini, G., & Brandi, M. L. (2017). Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. Journal of orthopaedics and traumatology, 18(Suppl 1), 3–36. https://doi.org/10.1007/s10195-017-0474-7
Yogui, F. C., Momesso, G., Faverani, L. P., Polo, T., Ramalho-Ferreira, G., Hassumi, J. S., Rossi, A. C., Freire, A. R., Prado, F. B., & Okamoto, R. (2018). A SERM increasing the expression of the osteoblastogenesis and mineralization-related proteins and improving quality of bone tissue in an experimental model of osteoporosis. Journal of applied oral science : revista FOB, 26, e20170329. https://doi.org/10.1590/1678-7757-2017-0329
Yu, J., Tang, J., Li, Z., Sajjan, S., O'Regan, C., Modi, A., & Sazonov, V. (2015). History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis. International journal of women's health, 7, 913–918. https://doi.org/10.2147/IJWH.S88627
Zacchetti, G., Dayer, R., Rizzoli, R., & Ammann, P. (2014). Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone. BioMed research international, 2014, 549785. https://doi.org/10.1155/2014/549785
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Fernanda Costa Yogui; Ana Cláudia Ervolino-Silva; Letícia Pitol-Palin; Juliana Zorzi Coléte; Jaqueline Suemi Hassumi; Naara Gabriela Monteiro; Fábio Roberto de Souza Batista; Pedro Henrique Silva Gomes-Ferreira; Roberta Okamoto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
